Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Income Statement
Earnings Waterfall
Henan Lingrui Pharmaceutical Co Ltd
Revenue
|
3.2B
CNY
|
Cost of Revenue
|
-903.2m
CNY
|
Gross Profit
|
2.3B
CNY
|
Operating Expenses
|
-1.8B
CNY
|
Operating Income
|
552m
CNY
|
Other Expenses
|
-25.8m
CNY
|
Net Income
|
526.2m
CNY
|
Income Statement
Henan Lingrui Pharmaceutical Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
662
N/A
|
687
+4%
|
718
+4%
|
757
+5%
|
802
+6%
|
826
+3%
|
901
+9%
|
936
+4%
|
1 006
+7%
|
1 085
+8%
|
1 147
+6%
|
1 225
+7%
|
1 315
+7%
|
1 439
+9%
|
1 514
+5%
|
1 609
+6%
|
1 697
+6%
|
1 849
+9%
|
1 990
+8%
|
2 120
+7%
|
2 139
+1%
|
2 053
-4%
|
2 078
+1%
|
2 118
+2%
|
2 149
+1%
|
2 157
+0%
|
2 068
-4%
|
2 163
+5%
|
2 215
+2%
|
2 332
+5%
|
2 430
+4%
|
2 513
+3%
|
2 635
+5%
|
2 694
+2%
|
2 786
+3%
|
2 841
+2%
|
2 917
+3%
|
3 002
+3%
|
3 108
+4%
|
3 200
+3%
|
3 232
+1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(289)
|
(292)
|
(304)
|
(319)
|
(331)
|
(335)
|
(367)
|
(379)
|
(396)
|
(405)
|
(423)
|
(434)
|
(453)
|
(471)
|
(499)
|
(524)
|
(531)
|
(498)
|
(546)
|
(556)
|
(538)
|
(493)
|
(516)
|
(520)
|
(526)
|
(494)
|
(501)
|
(514)
|
(522)
|
(538)
|
(593)
|
(647)
|
(697)
|
(702)
|
(769)
|
(806)
|
(838)
|
(832)
|
(890)
|
(885)
|
(903)
|
|
Gross Profit |
373
N/A
|
395
+6%
|
414
+5%
|
439
+6%
|
471
+7%
|
492
+4%
|
534
+9%
|
557
+4%
|
610
+10%
|
679
+11%
|
725
+7%
|
791
+9%
|
862
+9%
|
969
+12%
|
1 014
+5%
|
1 084
+7%
|
1 166
+8%
|
1 351
+16%
|
1 444
+7%
|
1 563
+8%
|
1 600
+2%
|
1 560
-3%
|
1 561
+0%
|
1 598
+2%
|
1 623
+2%
|
1 663
+2%
|
1 567
-6%
|
1 649
+5%
|
1 694
+3%
|
1 793
+6%
|
1 837
+2%
|
1 865
+2%
|
1 939
+4%
|
1 992
+3%
|
2 017
+1%
|
2 034
+1%
|
2 079
+2%
|
2 170
+4%
|
2 218
+2%
|
2 315
+4%
|
2 328
+1%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(322)
|
(334)
|
(354)
|
(386)
|
(417)
|
(430)
|
(452)
|
(457)
|
(490)
|
(542)
|
(579)
|
(628)
|
(686)
|
(792)
|
(838)
|
(879)
|
(945)
|
(1 082)
|
(1 150)
|
(1 258)
|
(1 281)
|
(1 233)
|
(1 239)
|
(1 262)
|
(1 273)
|
(1 311)
|
(1 246)
|
(1 309)
|
(1 364)
|
(1 452)
|
(1 507)
|
(1 523)
|
(1 571)
|
(1 586)
|
(1 595)
|
(1 631)
|
(1 652)
|
(1 729)
|
(1 769)
|
(1 789)
|
(1 776)
|
|
Selling, General & Administrative |
(314)
|
(302)
|
(342)
|
(372)
|
(402)
|
(401)
|
(447)
|
(453)
|
(489)
|
(508)
|
(578)
|
(626)
|
(685)
|
(740)
|
(817)
|
(856)
|
(923)
|
(1 029)
|
(1 159)
|
(1 271)
|
(1 288)
|
(1 185)
|
(1 216)
|
(1 228)
|
(1 239)
|
(1 232)
|
(1 183)
|
(1 231)
|
(1 259)
|
(1 347)
|
(1 396)
|
(1 412)
|
(1 473)
|
(1 506)
|
(1 529)
|
(1 567)
|
(1 587)
|
(1 638)
|
(1 658)
|
(1 683)
|
(1 674)
|
|
Research & Development |
0
|
(19)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(43)
|
0
|
0
|
0
|
(56)
|
0
|
0
|
(11)
|
(51)
|
(49)
|
(65)
|
(63)
|
(73)
|
(78)
|
(88)
|
(94)
|
(90)
|
(100)
|
(102)
|
(110)
|
(79)
|
(95)
|
(89)
|
(92)
|
(114)
|
(126)
|
(126)
|
(123)
|
|
Depreciation & Amortization |
0
|
(13)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
(34)
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(8)
|
(0)
|
(12)
|
(14)
|
(16)
|
(0)
|
(5)
|
(3)
|
(1)
|
1
|
(1)
|
(2)
|
(1)
|
4
|
(22)
|
(24)
|
(23)
|
21
|
8
|
14
|
18
|
33
|
27
|
32
|
29
|
24
|
16
|
11
|
(10)
|
19
|
(11)
|
(8)
|
13
|
29
|
28
|
25
|
27
|
53
|
15
|
20
|
21
|
|
Operating Income |
50
N/A
|
61
+21%
|
60
-2%
|
52
-12%
|
53
+2%
|
62
+15%
|
82
+33%
|
101
+23%
|
120
+19%
|
137
+14%
|
146
+6%
|
163
+12%
|
177
+9%
|
176
0%
|
176
+0%
|
205
+16%
|
221
+8%
|
268
+21%
|
294
+9%
|
306
+4%
|
320
+5%
|
327
+2%
|
323
-1%
|
337
+4%
|
350
+4%
|
352
+1%
|
321
-9%
|
341
+6%
|
330
-3%
|
341
+4%
|
330
-3%
|
342
+4%
|
368
+8%
|
405
+10%
|
422
+4%
|
403
-4%
|
427
+6%
|
440
+3%
|
449
+2%
|
526
+17%
|
552
+5%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
64
|
65
|
9
|
21
|
29
|
19
|
23
|
24
|
9
|
12
|
11
|
8
|
247
|
243
|
247
|
244
|
14
|
(3)
|
(11)
|
(19)
|
(24)
|
(29)
|
(1)
|
0
|
2
|
(10)
|
(9)
|
(7)
|
17
|
54
|
60
|
78
|
60
|
30
|
53
|
84
|
88
|
76
|
86
|
43
|
47
|
|
Non-Reccuring Items |
0
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(4)
|
(0)
|
(1)
|
(1)
|
(0)
|
0
|
(0)
|
(0)
|
(28)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
1
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
1
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
Total Other Income |
4
|
1
|
1
|
2
|
2
|
6
|
6
|
7
|
8
|
6
|
9
|
9
|
8
|
5
|
7
|
4
|
4
|
(1)
|
(7)
|
(6)
|
(7)
|
1
|
(11)
|
(11)
|
(11)
|
0
|
(0)
|
0
|
0
|
0
|
(3)
|
(2)
|
(2)
|
(1)
|
(22)
|
(22)
|
(22)
|
0
|
(1)
|
(1)
|
(1)
|
|
Pre-Tax Income |
118
N/A
|
123
+4%
|
69
-43%
|
75
+8%
|
84
+12%
|
86
+3%
|
111
+29%
|
131
+19%
|
136
+4%
|
154
+13%
|
164
+6%
|
180
+9%
|
432
+140%
|
409
-5%
|
431
+5%
|
453
+5%
|
239
-47%
|
264
+10%
|
273
+4%
|
279
+2%
|
287
+3%
|
283
-1%
|
311
+10%
|
325
+5%
|
340
+5%
|
341
+0%
|
312
-9%
|
334
+7%
|
347
+4%
|
364
+5%
|
387
+6%
|
418
+8%
|
426
+2%
|
413
-3%
|
453
+10%
|
464
+2%
|
494
+6%
|
517
+5%
|
534
+3%
|
568
+6%
|
598
+5%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(15)
|
(17)
|
(10)
|
(9)
|
(9)
|
(10)
|
(14)
|
(17)
|
(17)
|
(21)
|
(22)
|
(25)
|
(64)
|
(61)
|
(64)
|
(68)
|
(37)
|
(39)
|
(42)
|
(41)
|
(41)
|
(38)
|
(40)
|
(46)
|
(49)
|
(48)
|
(43)
|
(47)
|
(46)
|
(40)
|
(42)
|
(50)
|
(42)
|
(51)
|
(57)
|
(52)
|
(53)
|
(52)
|
(55)
|
(56)
|
(72)
|
|
Income from Continuing Operations |
103
|
105
|
59
|
66
|
75
|
76
|
97
|
115
|
119
|
133
|
142
|
155
|
368
|
348
|
367
|
384
|
202
|
225
|
231
|
238
|
246
|
246
|
270
|
279
|
291
|
293
|
269
|
287
|
301
|
324
|
345
|
368
|
384
|
362
|
397
|
413
|
440
|
465
|
479
|
512
|
526
|
|
Income to Minority Interest |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(8)
|
(9)
|
(8)
|
(7)
|
(3)
|
(0)
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
Net Income (Common) |
103
N/A
|
105
+3%
|
59
-44%
|
65
+10%
|
75
+14%
|
76
+2%
|
97
+27%
|
115
+19%
|
119
+3%
|
132
+11%
|
141
+7%
|
152
+8%
|
365
+140%
|
346
-5%
|
365
+5%
|
381
+5%
|
198
-48%
|
217
+9%
|
223
+3%
|
230
+3%
|
239
+4%
|
243
+2%
|
270
+11%
|
280
+4%
|
292
+4%
|
294
+1%
|
270
-8%
|
288
+7%
|
302
+5%
|
326
+8%
|
346
+6%
|
368
+6%
|
383
+4%
|
362
-6%
|
396
+9%
|
412
+4%
|
440
+7%
|
465
+6%
|
479
+3%
|
512
+7%
|
526
+3%
|
|
EPS (Diluted) |
0.2
N/A
|
0.2
N/A
|
0.11
-45%
|
0.13
+18%
|
0.14
+8%
|
0.14
N/A
|
0.19
+36%
|
0.22
+16%
|
0.23
+5%
|
0.25
+9%
|
0.26
+4%
|
0.23
-12%
|
0.61
+165%
|
0.58
-5%
|
0.6
+3%
|
0.64
+7%
|
0.34
-47%
|
0.37
+9%
|
0.39
+5%
|
0.4
+3%
|
0.41
+2%
|
0.41
N/A
|
0.45
+10%
|
0.47
+4%
|
0.49
+4%
|
0.51
+4%
|
0.47
-8%
|
0.51
+9%
|
0.54
+6%
|
0.57
+6%
|
0.61
+7%
|
0.65
+7%
|
0.68
+5%
|
0.64
-6%
|
0.7
+9%
|
0.73
+4%
|
0.78
+7%
|
0.84
+8%
|
0.86
+2%
|
0.92
+7%
|
0.94
+2%
|